HK Stock Market Move | E-HOUSE ENT (02048) rose over 39%, achieving a turnaround from loss to profit in the first half of the year, with the overseas debt restructuring plan receiving overwhelming approval.

E-HOUSE ENT (02048) surged over 39%. As of the time of writing, it rose by 39.29%, priced at HK$0.039, with a trading volume of HK$1.8445 million. In terms of news, E-HOUSE ENT released its interim results for 2026 last night, reporting revenues of 813 million yuan, a decrease of 35.54% year-on-year; the profit attributable to shareholders was 45.245 million yuan, compared to a loss of 298 million yuan during the same period last year. Additionally, the board announced that Ding Zuyu has resigned as an executive director to devote more time to other business commitments, effective August 31. He confirmed that there are no disagreements with the board and no matters related to his resignation require shareholder attention. Notably, the company has achieved a significant milestone in its offshore debt restructuring. Both the Hong Kong scheme and the Cayman scheme received the necessary majority approval from plan creditors. The court hearings for the Hong Kong scheme and the Cayman scheme are scheduled for September 11, 2026, and October 9, 2026, respectively. The company stated that it will continue its unremitting efforts, expecting to successfully and timely complete the debt restructuring.